Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01194687 · ClinicalTrials.gov registry record
Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota Analyses
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 98
- Enrollment target
NCT01194687: Completed study, sponsored by National Cancer Institute (NCI).
NCT01194687 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01194687 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
Background: \- Bacteria and other micro-organisms in the intestines play important roles in immunity and other health conditions. As a result, these micro-organisms are likely to affect many health conditions, including several types of cancer. Because cancer and other diseases may affect the digestive system and the bacteria within it, fecal samples that are taken both before and after the onset of a disease may show important changes in the body and provide information about possible treatments. However, unlike repositories of blood and tissue samples, researchers do not have a repository of fecal specimens. Researchers are interested in determining whether standard collection procedures used for fecal occult blood testing can provide accurate information on micro-organisms in the intestine. Objectives: \- To determine whether standard fecal occult blood testing procedures can provide accurate collections of fecal micro-organisms for research purposes. Eligibility: \- Healthy volunteers at least 18 years of age. Design: * At the clinical center, participants will be provided with written and illustrated instructions for the collection procedures and a self-administered risk questionnaire. The questionnaire will assess the challenges of collecting fecal specimens and will collect data on major dietary restrictions (e.g., vegan, vegetarian, food allergies), medication use and major illnesses, knowledge of and past experience with fecal occult blood testing, colonoscopy and colon cancer, and the fecal collection devices. * Participants will be provided with a collection bag for the sample, 16 sample collection tubes, and a box with frozen gel packs. * On the morning of collection, participants will collect the fecal sample in the bag and use the collection tubes to obtain material from different parts of the stool. * The tubes will be sealed and placed in the box with the gel packs, and the participant will hand deliver the entire box to the clinical center. *
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2010-04-27 |
| Est. Completion | 2018-09-14 |
What the finished NCT01194687 record still lists
NCT01194687 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 98 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01194687 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01194687 about?
NCT01194687 is a clinical study titled "Reproducibility of a Fecal Occult Blood Test Device for Gut Microbiota Analyses". Background: \- Bacteria and other micro-organisms in the intestines play important roles in immunity and other health conditions. As a result, these micro-organisms are likely to affect many health conditions, including several types of cancer. Because cancer and other diseases may affect the diges...
What is the current status of trial NCT01194687?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2010-04-27. Estimated completion is 2018-09-14.
Who is sponsoring clinical trial NCT01194687?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI